Caricamento...

X-Ray Crystal Structures of Human Immunodeficiency Virus Type 1 Protease Mutants Complexed with Atazanavir

Atazanavir, which is marketed as REYATAZ, is the first human immunodeficiency virus type 1 (HIV-1) protease inhibitor approved for once-daily administration. As previously reported, atazanavir offers improved inhibitory profiles against several common variants of HIV-1 protease over those of the oth...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Klei, Herbert E., Kish, Kevin, Lin, Pin-Fang M., Guo, Qi, Friborg, Jacques, Rose, Ronald E., Zhang, Yaqun, Goldfarb, Valentina, Langley, David R., Wittekind, Michael, Sheriff, Steven
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Microbiology 2007
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC1951392/
https://ncbi.nlm.nih.gov/pubmed/17537865
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.02503-05
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !